Design Therapeutics Cash Flow Statement (2020-2026) | DSGN

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-15.96M-11.37M-15.77M-21.46M-24.60M-20.41M-24.45M-24.62M-19.39M-48.30M-13.30M-14.00M-15.31M-16.29M-20.26M-21.82M-19.27M-18.18M-20.99M-23.39M
Depreciation and Depletion (Quarter)
0.03M0.08M0.08M0.09M0.11M0.12M0.13M0.13M0.14M0.14M0.14M0.15M0.15M0.15M0.16M0.15M0.15M0.16M0.16M0.15M
Share-based Compensation (Quarter)
1.24M1.56M2.36M2.62M2.87M3.08M3.43M3.72M3.22M2.72M3.18M3.30M3.12M3.47M3.54M3.98M3.59M3.44M3.92M3.87M
Cash from Operations (Quarter)
-8.16M-9.23M-11.83M-10.50M-13.90M-15.09M-17.42M-13.80M-14.53M-12.80M-12.44M-11.26M-9.55M-9.86M-16.79M-14.44M-11.16M-11.97M-16.43M-15.52M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.03M-0.03M-0.02M0.06M0.46M0.90M1.14M1.40M1.71M1.84M1.73M1.57M1.46M1.44M1.06M0.91M0.77M0.51M0.15M0.01M
Amortization of Deferred Charges (Quarter)
0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M-0.00M
Depreciation & Amortization (CF) (Quarter)
0.03M0.08M0.08M0.09M0.11M0.12M0.13M0.13M0.14M0.14M0.14M0.15M0.15M0.15M0.16M0.15M0.15M0.16M0.16M0.15M
Change in Working Capital
Change in Accured Expenses (Quarter)
1.37M-0.03M0.21M1.60M3.16M0.42M-1.75M3.07M0.24M-2.81M-2.52M-0.72M1.02M1.01M-0.30M0.54M2.40M1.84M-2.51M0.95M
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
0.97M0.35M0.02M0.20M-0.16M0.86M0.09M0.09M0.05M-0.20M0.20M0.16M-0.02M0.07M0.09M0.03M0.02M
Change in Acquisitions & Divestments (Quarter)
0.24M0.20M0.49M1.23M30.93M60.24M53.44M74.44M69.89M79.73M66.47M81.12M60.67M66.20M94.49M59.73M84.58M76.08M45.00M27.50M
Cash from Investing Activities (Quarter)
-5.04M-50.06M0.41M-156.96M-63.39M-1.06M19.73M11.98M15.27M5.55M20.62M27.33M-5.83M1.83M7.87M20.12M6.51M-11.58M-7.59M15.06M
Financing Activities
Other financing activities (Quarter)
-254.24M254.24M0.16M0.15M-0.01M0.01M0.38M0.02M0.01M0.00M0.01M0.02M0.04M0.18M0.03M0.14M
Change in Capital Stock
Shares Issued (Quarter)
2.67M5.06M5.32M5.28M5.40M7.91M8.01M9.11M8.56M10.71M10.68M10.63M10.33M13.46M13.78M13.86M13.76M17.32M17.42M
Net Equity Issued and Repurchased (Quarter)
19.91M
Misc.
Cash from Financing Activities (Quarter)
0.03M0.19M0.16M-0.20M0.15M0.13M0.01M0.50M0.02M0.23M0.00M0.26M0.02M0.36M0.04M25.32M19.93M0.60M
Change in Cash (Quarter)
-13.18M-59.09M-11.26M-167.66M-77.14M-16.02M2.31M-1.61M0.74M-6.74M8.20M16.30M-15.37M-7.76M-8.90M6.04M-4.62M1.77M-4.09M0.14M
Free Cash Flow (Quarter)
-9.13M-9.58M-11.85M-10.70M-13.74M-15.95M-17.51M-13.89M-14.59M-12.59M-12.63M-11.42M-9.53M-9.86M-16.86M-14.53M-11.16M-12.00M-16.43M-15.54M
Net Cash Flow (Quarter)
-13.18M-59.09M-11.26M-167.66M-77.14M-16.02M2.31M-1.82M0.74M-6.74M8.20M16.30M-15.37M-7.76M-8.90M6.04M-4.62M1.77M-4.09M0.14M